Cargando…
New strategies against drug resistance to herpes simplex virus
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a significant human pathogen that results in mucocutaneous lesions in the oral cavity or genital infections. Acyclovir (ACV) and related nucleoside analogues can successfully treat HSV infections, but the emergence of drug resistan...
Autores principales: | Jiang, Yu-Chen, Feng, Hui, Lin, Yu-Chun, Guo, Xiu-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822185/ https://www.ncbi.nlm.nih.gov/pubmed/27025259 http://dx.doi.org/10.1038/ijos.2016.3 |
Ejemplares similares
-
Inhibitory effects of baicalein against herpes simplex virus type 1
por: Luo, Zhuo, et al.
Publicado: (2020) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Antiviral Activity of Oridonin Against Herpes Simplex Virus Type 1
por: Jiang, Kai, et al.
Publicado: (2022) -
Successful Confirmation of Dual Genital Herpes Co-Infection with Herpes Simplex Virus 1 and Herpes Simplex Virus 2 Using Unbiased Metagenomic Next-Generation Sequencing
por: Lee, Chun Kiat, et al.
Publicado: (2023) -
Antiviral activity of theaflavin digallate against herpes simplex virus type 1
por: de Oliveira, Aline, et al.
Publicado: (2015)